• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Symptomatic Bevacizumab-Induced Cerebral Infarction Following Treatment for Radiation Necrosis.

作者信息

Maramattom Boby V

机构信息

Department of Neurology, Lourdes Hospital, Kochi, Kerala, India.

出版信息

Ann Indian Acad Neurol. 2025 Mar 1;28(2):278-280. doi: 10.4103/aian.aian_645_24. Epub 2025 Feb 6.

DOI:10.4103/aian.aian_645_24
PMID:39915965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12049207/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38b6/12049207/0944b93f0364/AIAN-28-278-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38b6/12049207/0944b93f0364/AIAN-28-278-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38b6/12049207/0944b93f0364/AIAN-28-278-g001.jpg

相似文献

1
Symptomatic Bevacizumab-Induced Cerebral Infarction Following Treatment for Radiation Necrosis.放射坏死治疗后出现的贝伐单抗所致有症状性脑梗死
Ann Indian Acad Neurol. 2025 Mar 1;28(2):278-280. doi: 10.4103/aian.aian_645_24. Epub 2025 Feb 6.
2
Ultra-Low-Dose Bevacizumab For Cerebral Radiation Necrosis: A Prospective Phase II Clinical Study.超低剂量贝伐单抗治疗脑放射性坏死：一项前瞻性II期临床研究。
Onco Targets Ther. 2019 Oct 11;12:8447-8453. doi: 10.2147/OTT.S223258. eCollection 2019.
3
A study on the evaluation method and recent clinical efficacy of bevacizumab on the treatment of radiation cerebral necrosis.贝伐单抗治疗放射性脑坏死的评估方法及近期临床疗效研究
Sci Rep. 2016 Apr 12;6:24364. doi: 10.1038/srep24364.
4
Bevacizumab is an effective treatment for symptomatic cerebral necrosis after carbon ion therapy for recurrent intracranial malignant tumours: A case report.贝伐单抗是复发性颅内恶性肿瘤碳离子治疗后症状性脑坏死的有效治疗方法：一例报告。
Mol Clin Oncol. 2022 May 19;17(1):114. doi: 10.3892/mco.2022.2547. eCollection 2022 Jul.
5
Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients.17 例中国患者接受贝伐珠单抗治疗后脑放射性坏死逆转。
Eur J Med Res. 2012 Aug 23;17(1):25. doi: 10.1186/2047-783X-17-25.
6
Bevacizumab reduces cerebral radiation necrosis due to stereotactic radiotherapy in non-small cell lung cancer patients with brain metastases: an inverse probability of treatment weighting analysis.贝伐珠单抗可降低非小细胞肺癌脑转移患者立体定向放疗所致的放射性脑坏死：一项逆概率治疗加权分析。
Front Immunol. 2024 Aug 27;15:1399613. doi: 10.3389/fimmu.2024.1399613. eCollection 2024.
7
Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab.使用贝伐单抗治疗的皮质类固醇难治性脑放射性坏死患者的肾上腺功能不全
J Clin Med. 2019 Oct 3;8(10):1608. doi: 10.3390/jcm8101608.
8
Long-Term Relief of Cerebral Radiation Necrosis Treated with Low-Dose Bevacizumab - a Report of 2 Cases.低剂量贝伐珠单抗治疗脑放射性坏死的长期缓解-2 例报告。
Oncol Res Treat. 2017;40(3):133-137. doi: 10.1159/000455868. Epub 2017 Feb 24.
9
Bevacizumab for pediatric radiation necrosis.贝伐单抗用于小儿放射性坏死
Neurooncol Pract. 2020 Jul;7(4):409-414. doi: 10.1093/nop/npz072. Epub 2020 Jan 20.
10
Bevacizumab treatment in malignant meningioma with additional radiation necrosis. An MRI diffusion and perfusion case study.贝伐单抗治疗伴有放射性坏死的恶性脑膜瘤。磁共振弥散和灌注病例研究。
Strahlenther Onkol. 2014 Apr;190(4):416-21. doi: 10.1007/s00066-013-0505-0. Epub 2014 Jan 17.

本文引用的文献

1
Central Nervous System Ischemia Associated with Bevacizumab: An Analysis of the Japanese Adverse Drug Event Report Database.贝伐单抗相关的中枢神经系统缺血：日本药品不良事件报告数据库分析
Biol Pharm Bull. 2022;45(12):1805-1811. doi: 10.1248/bpb.b22-00496.
2
Case Report: Probable Cerebral Amyloid Angiopathy-Related Inflammation During Bevacizumab Treatment for Metastatic Cervical Cancer.病例报告：贝伐单抗治疗转移性宫颈癌期间可能发生的与脑淀粉样血管病相关的炎症
Front Oncol. 2021 Jul 27;11:669753. doi: 10.3389/fonc.2021.669753. eCollection 2021.
3
Bevacizumab Treatment of Radiation-Induced Brain Necrosis: A Systematic Review.
贝伐单抗治疗放射性脑坏死：一项系统评价。
Front Oncol. 2021 Mar 25;11:593449. doi: 10.3389/fonc.2021.593449. eCollection 2021.
4
Mortality after a cerebrovascular event in age-related macular degeneration patients treated with bevacizumab ocular injections.年龄相关性黄斑变性患者接受贝伐单抗眼内注射后的脑血管事件死亡率。
Acta Ophthalmol. 2018 Sep;96(6):e732-e739. doi: 10.1111/aos.13731. Epub 2018 Apr 16.
5
Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis.接受贝伐单抗治疗的癌症患者发生脑血管事件的风险增加：一项荟萃分析。
PLoS One. 2014 Jul 15;9(7):e102484. doi: 10.1371/journal.pone.0102484. eCollection 2014.
6
Vertebral artery dissection and cerebral infarction in a patient with recurrent ovarian cancer receiving bevacizumab.一名接受贝伐单抗治疗的复发性卵巢癌患者发生椎动脉夹层和脑梗死。
Gynecol Oncol Case Rep. 2013 Apr 11;5:37-9. doi: 10.1016/j.gynor.2013.04.002. eCollection 2013.
7
Cerebrovascular events after bevacizumab treatment: an early and severe complication.贝伐珠单抗治疗后的脑血管事件：一种早期且严重的并发症。
Neurocrit Care. 2011 Dec;15(3):421-7. doi: 10.1007/s12028-011-9552-5.
8
Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice.贝伐单抗免疫复合物激活血小板并在FCGR2A转基因小鼠中诱导血栓形成。
J Thromb Haemost. 2009 Jan;7(1):171-81. doi: 10.1111/j.1538-7836.2008.03212.x. Epub 2008 Oct 30.